TMDX 8-K 2026-11-05

TransMedics Group, Inc. (TMDX) 8-K dated 2026-11-05 — accession 0001193125-26-449729.

TransMedics Group, Inc. (TMDX) is a medical devices company listed on NASDAQ.

TransMedics Group, Inc. filed a 8-K on 2026-11-05. Accession 0001193125-26-449729.

This 8-K covers: Results of operations (Item 2.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported TMDX revenue for 2025-12-31 was $605.5M. Net income was $190.3M. Revenue was up 37.1% from 2024-12-31 to 2025-12-31. TMDX currently screens at market cap $2.53B.

Not investment advice. The TMDX SEC hub lists recent forms. The stock page is the research view.